Israeli pharmaceutical company Raziel Therapeutics announced this week a $22 million Series C preferred stock financing led by Israeli VC firm Pontifax, with the participation of existing investors Dr. Shmuel Cabilly and Docor International. New investors included Catalyst Fund, Quark Venture and Peregrine Ventures. The Jerusalem-based company, founded in 2012 as part of the Hebrew […]